The Impact and Relevance of Techniques and Fluids on Lung Injury in Machine Perfusion of Lungs

Overview

Journal Front Immunol

Specialty Allergy & Immunology

Date 2024 Mar 21

PMID 38510260

Authors

Florian Ponholzer

Julia Dumfarth

Christoph Krapf

Andreas Pircher

Theresa Hautz

Dominik Wolf

Florian Augustin

Stefan Schneeberger

Affiliations

Soon will be listed here.

Abstract

Primary graft dysfunction (PGD) is a common complication after lung transplantation. A plethora of contributing factors are known and assessment of donor lung function prior to organ retrieval is mandatory for determination of lung quality. Specialized centers increasingly perform ex vivo lung perfusion (EVLP) to further assess lung functionality and improve and extend lung preservation with the aim to increase lung utilization. EVLP can be performed following different protocols. The impact of the individual EVLP parameters on PGD development, organ function and postoperative outcome remains to be fully investigated. The variables relate to the engineering and function of the respective perfusion devices, such as the type of pump used, functional, like ventilation modes or physiological (e.g. perfusion solutions). This review reflects on the individual technical and fluid components relevant to EVLP and their respective impact on inflammatory response and outcome. We discuss key components of EVLP protocols and options for further improvement of EVLP in regard to PGD. This review offers an overview of available options for centers establishing an EVLP program and for researchers looking for ways to adapt existing protocols.

References

Porto B, Stein R . Neutrophil Extracellular Traps in Pulmonary Diseases: Too Much of a Good Thing?. Front Immunol. 2016; 7:311. PMC: 4983612. DOI: 10.3389/fimmu.2016.00311. View

Delivani P, Martin S . Mitochondrial membrane remodeling in apoptosis: an inside story. Cell Death Differ. 2006; 13(12):2007-10. DOI: 10.1038/sj.cdd.4402049. View

Delivani P, Adrain C, Taylor R, Duriez P, Martin S . Role for CED-9 and Egl-1 as regulators of mitochondrial fission and fusion dynamics. Mol Cell. 2006; 21(6):761-73. DOI: 10.1016/j.molcel.2006.01.034. View

Linacre V, Cypel M, Machuca T, Nakajima D, Hashimoto K, Zamel R . Importance of left atrial pressure during ex vivo lung perfusion. J Heart Lung Transplant. 2016; 35(6):808-14. DOI: 10.1016/j.healun.2016.02.008. View

Terada L, Piermattei D, Shibao G, McManaman J, Wright R . Hypoxia regulates xanthine dehydrogenase activity at pre- and posttranslational levels. Arch Biochem Biophys. 1997; 348(1):163-8. DOI: 10.1006/abbi.1997.0367. View

Kniepeiss D, Houben P, Stiegler P, Berghold A, Riedl R, Kahn J . A prospective, randomized, single-blind, multicentre, phase III study on organ preservation with Custodiol-N solution compared with Custodiol® solution in organ transplantation (kidney, liver and pancreas). Trials. 2020; 21(1):62. PMC: 6954515. DOI: 10.1186/s13063-019-3823-4. View

Bates J, Smith B . Ventilator-induced lung injury and lung mechanics. Ann Transl Med. 2018; 6(19):378. PMC: 6212358. DOI: 10.21037/atm.2018.06.29. View

Buchko M, Boroumand N, Cheng J, Hirji A, Halloran K, Freed D . Clinical transplantation using negative pressure ventilation ex situ lung perfusion with extended criteria donor lungs. Nat Commun. 2020; 11(1):5765. PMC: 7666579. DOI: 10.1038/s41467-020-19581-4. View

Helmerhorst H, Schultz M, van der Voort P, de Jonge E, van Westerloo D . Bench-to-bedside review: the effects of hyperoxia during critical illness. Crit Care. 2015; 19:284. PMC: 4538738. DOI: 10.1186/s13054-015-0996-4. View

10.

Wallinder A, Ricksten S, Hansson C, Riise G, Silverborn M, Liden H . Transplantation of initially rejected donor lungs after ex vivo lung perfusion. J Thorac Cardiovasc Surg. 2012; 144(5):1222-8. DOI: 10.1016/j.jtcvs.2012.08.011. View

11.

Lee J, Christie J . Primary graft dysfunction. Proc Am Thorac Soc. 2009; 6(1):39-46. DOI: 10.1513/pats.200808-082GO. View

12.

Buchko M, Stewart C, Hatami S, Himmat S, Freed D, Nagendran J . Total parenteral nutrition in ex vivo lung perfusion: Addressing metabolism improves both inflammation and oxygenation. Am J Transplant. 2019; 19(12):3390-3397. DOI: 10.1111/ajt.15572. View

13.

Nakajima D, Cypel M, Bonato R, Machuca T, Iskender I, Hashimoto K . Ex Vivo Perfusion Treatment of Infection in Human Donor Lungs. Am J Transplant. 2016; 16(4):1229-37. DOI: 10.1111/ajt.13562. View

14.

Sayah D, Mallavia B, Liu F, Ortiz-Munoz G, Caudrillier A, DerHovanessian A . Neutrophil extracellular traps are pathogenic in primary graft dysfunction after lung transplantation. Am J Respir Crit Care Med. 2014; 191(4):455-63. PMC: 4351593. DOI: 10.1164/rccm.201406-1086OC. View

15.

Valapour M, Lehr C, Skeans M, Smith J, Miller E, Goff R . OPTN/SRTR 2019 Annual Data Report: Lung. Am J Transplant. 2021; 21 Suppl 2:441-520. DOI: 10.1111/ajt.16495. View

16.

Hashimoto K, Kim H, Oishi H, Chen M, Iskender I, Sakamoto J . Annexin V homodimer protects against ischemia reperfusion-induced acute lung injury in lung transplantation. J Thorac Cardiovasc Surg. 2016; 151(3):861-869. DOI: 10.1016/j.jtcvs.2015.10.112. View

17.

Loor G, Howard B, Spratt J, Mattison L, Panoskaltsis-Mortari A, Brown R . Prolonged EVLP Using OCS Lung: Cellular and Acellular Perfusates. Transplantation. 2016; 101(10):2303-2311. PMC: 5481503. DOI: 10.1097/TP.0000000000001616. View

18.

Andreasson A, Karamanou D, Perry J, Perry A, zalp F, Butt T . The effect of ex vivo lung perfusion on microbial load in human donor lungs. J Heart Lung Transplant. 2014; 33(9):910-6. DOI: 10.1016/j.healun.2013.12.023. View

19.

Van Raemdonck D, Neyrinck A, Cypel M, Keshavjee S . Ex-vivo lung perfusion. Transpl Int. 2014; 28(6):643-56. DOI: 10.1111/tri.12317. View

20.

Talaie T, DiChiacchio L, Prasad N, Pasrija C, Julliard W, Kaczorowski D . Ischemia-reperfusion Injury in the Transplanted Lung: A Literature Review. Transplant Direct. 2021; 7(2):e652. PMC: 7793349. DOI: 10.1097/TXD.0000000000001104. View